Advertisement

MAIP program admits 56,624 in Calabarzon

A total 56,624 patients had been admitted to the Medical Assistance for Indigents Program of the Department of Health in CALABARZON (Cavite, Laguna, Batangas, Rizal, Quezon) from January to December of 2019. 

There are 51,516 regular patients granted and 5,108 Dengvaxia patients provided with medical assistance with a total of P144,942,786.05 and P7,773,819.04, respectively.

Regional Director Eduardo Janairo said the beneficiaries of MAIP will now have more options where to get medical treatment as more private hospitals in the region are now committed to provide medical treatment to indigent patients through the medical assistance program. 

“Medical assistance is not only the giving of money or financial assistance to the needy.  What  is important  here  is taking care of them from hospitalization until they can be treated and can return to their houses,” said Janairo. 

 Janairo further said this was not only for the poor. He said government  employees can also be assisted  and those facing crisis and needing financial help for their medication. 

The regional office continues to monitor students who received the Dengvaxia vaccine and provide medical assistance to those needing medical treatment. 

Janairo disclosed that Dengvaxia vaccinees will continue to be observed and assessed for two more years to be able to know the adverse reactions as a result of the vaccination done in 2016.

Topics: Medical Assistance for Indigents Program , Department of Health , DOH , CALABARZON , Dengvaxia vaccine
COMMENT DISCLAIMER: Reader comments posted on this Web site are not in any way endorsed by Manila Standard. Comments are views by manilastandard.net readers who exercise their right to free expression and they do not necessarily represent or reflect the position or viewpoint of manilastandard.net. While reserving this publication’s right to delete comments that are deemed offensive, indecent or inconsistent with Manila Standard editorial standards, Manila Standard may not be held liable for any false information posted by readers in this comments section.
AdvertisementKPPI
Advertisement